期刊文献+

苦参素胶囊对慢性乙型肝炎的治疗效果研究 被引量:8

Treatment efficacy of Kushensu capsule in treating chronic hepatitis B
暂未订购
导出
摘要 目的:探讨慢性乙型肝炎患者采取苦参素胶囊治疗的效果。方法:比较分析乙肝清热解毒片(对照组,n=40)与苦参素胶囊(研究组,n=50)治疗慢性乙型肝炎的临床效果。结果:研究组总有效率为94.00%,显著高于对照组的70.00%(P<0.05);两组治疗后ALT与TBi L均有改善(P<0.05),研究组改善更显著(P<0.05);研究组HBV-M变化明显优于对照组(P<0.05)。结论:慢性乙型肝炎采取苦参素胶囊治疗,不仅能显著改善肝功能指标与HBV-M指标,同时能明显提高临床效果,值得借鉴。 Objective:To investigate the effect of Kushensu capsule in treating patients with chronic hepatitis B.Methods:A comparative analysis of clinical effect of hepatitis B detoxification tablets(control group,n=40)and Kushensu capsule(study group,n=50)in the treatment of chronic hepatitis B was made.Results:The total effective rate of the study group was94.00%,which was significantly higher than that of the control group,70.00%(P<0.05);After treatment,ALT and TBiL were improved(P<0.05),the study group improved more significantly(P<0.05);changes of HBV-M in the study group improved more significantly(P<0.05).Conclusion:Kushensu capsule treatment could not only significantly improve the liver function and HBV-M index,but also significantly improve the clinical effects,it was worth learning from.
作者 黄向春
出处 《中医临床研究》 2017年第3期57-58,共2页 Clinical Journal Of Chinese Medicine
关键词 慢性乙型肝炎 苦参素胶囊 治疗 效果 Chronic hepatitis B Kushensu capsule Treatment Effect
  • 相关文献

参考文献5

二级参考文献31

  • 1林宗梅,王蓓蓓,林秀芳,陈春雷.干扰素治疗慢性乙型肝炎的临床效果及影响因素分析[J].中国生化药物杂志,2014,34(2):109-110. 被引量:26
  • 2吴春晓,陈燕鸿,郑志雄.苦参碱联合复方丹参对慢性乙型肝炎肝纤维化的影响[J].实用医学杂志,2006,22(13):1567-1568. 被引量:18
  • 3Shaw T, Locarnini S. Entecavir for the treatment of chronic hepatitis B [ J ]. Exp Rev Anti Infect Ther,2004 ;2:853 -871.
  • 4Eun JR. Comparson of clinical outcome between patients con- tinuing and discontinuing lamivudine therapy in acute exacer- bation after viral breakthrough during lamivudine therapy in chronic hepatitis B. Korean J Heptol, 2006,12(2) 184-190.
  • 5Lek AS, McMahon BJ. The American Association for the study of Liver Diseases(AASLD). Chronic hepatitis B. Hcpatology, 2007,45(2) ..507-539.
  • 6Keeffe EB, Dieterich DT, Han SH, et al. A treatment algorithm for the management of Chronic hepatitis 13 virus infection in the united states; 2008 update. Clin Gastroenterol Hepatol, 2008,6(12) : 1315-1341.
  • 7European Association for the Study of Liver. EASL clinical practice guideline: management of the chronic hepatitis B. J Hepatol, 2009,50 (2) .. 227-242.
  • 8Liaw YF, Sung J1, Chow WC, et al. Lamivudine for patients with chronic hepatitis B and advanced liver disease. N Engl J Meal,2004,351 : 1521-1531.
  • 9EUN JR. Comparison of the clinical outcome between patients con- tinuing and discontinuing lamivudine therapy in acute exacerbation after viral breakthrough during lamivudine therapy in chronic hepa- titis B. Korean J Heptol, 2006,12 : 184-190.
  • 10鲁国兴.苦参素治疗慢性乙型肝炎46例分析[J].内科,2008,3(1):45-46. 被引量:1

共引文献23

同被引文献163

引证文献8

二级引证文献44

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部